Author: Ken Dropiewski

Neurescue’s Breakthrough Intelligent Balloon Catheter FDA 510(k) Cleared for Hemorrhage Control and IDE Approved for Cardiac Arrest

Device is FDA IDE approved to start a clinical study in the U.S. to investigate a novel cardiac arrest treatment indication COPENHAGEN, Denmark–(BUSINESS WIRE)–Neurescue, a medical device company developing innovative cardiovascular solutions to improve the outcomes for emergency patients, today announced that the U.S. Food and Drug Administration (FDA) has […]

Peijia Medical Partners with inQB8 for US Incubator and Transcatheter Tricuspid Replacement (TTVR) Product

SUZHOU, China, June 9, 2021 /PRNewswire/ — Peijia Medical (HKEX:9996, or “Peijia“), a leading player in China for medical technology, announced a partnership with inQB8, a Boston based medical technology incubator, to explore innovative solutions for Structural Heart Disease. This partnership includes Peijia’s acquisition of a transcatheter tricuspid replacement technology (“TTVR”, or “inQB8 TTVR”) from inQB8, which is currently in […]

CVRx® Announces First Clinical Procedure with a New Ultrasound-Guided Implant Approach, the Latest Advancement in Barostim™ for the Treatment of Heart Failure Symptoms

MINNEAPOLIS, June 10, 2021 (GLOBE NEWSWIRE) — CVRx®, developer of the world’s first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF), announced the completion of the first clinical procedure with the company’s new lead implantation approach. The novel ultrasound-guided technique is the latest advancement of CVRx’s Barostim™ Baroreflex Activation […]

vMap™’s Role in Optimizing Non-Invasive Radio-Ablation Therapy presented at ACC.21 and THRS 2021

A dual-center study from UCSD Health and Mills-Peninsula Sutter Health concluded that a simplified, non-invasive radio-ablation workflow, involving vMap™, was Feasible, Efficient, and Precise CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a dual-center study reports that vMap™, as part of a new, non-invasive workflow, improved efficiency and precision for radio-ablation therapy […]

Canon Medical’s Digital PET/CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology

Advanced intelligent Clear-IQ Engine (AiCE) for PET will be introduced at SNMMI 2021 on Cartesion Prime , Further Expanding the Technology Across Modalities and into Molecular Imaging TUSTIN, Calif.–(BUSINESS WIRE)–Bringing the power of artificial intelligence (AI) to molecular imaging, Advanced intelligent Clear-IQ Engine (AiCE), Canon Medical Systems USA Inc.’s Deep Learning […]

Able Medical Announces First Surgeries and Launch of the Valkyrie™ Thoracic Fixation System

A novel single-use, bioactive sternal plating system for use after open heart surgery. MARQUETTE, Mich.–(BUSINESS WIRE)–Able Medical Devices announces the recent launch of its Valkyrie™ Thoracic Fixation System, the market’s first single-use radiolucent plating system designed to span the osteotomy and close the sternum after open heart surgery. The system’s […]

Predictive Health Diagnostics Company Announces Strong Momentum with 120,000th PULS Cardiac Test™ Order

One-of-a-kind diagnostic blood test identifies asymptomatic at-risk patients missed by the current standard of care IRVINE, Calif., June 9, 2021 /PRNewswire/ — Predictive Health Diagnostics Company, Inc. (“PHDC” or “the Company”), a diagnostics development platform company that develops, manufactures, and distributes specialty diagnostic tests combining science, technology, and proprietary analytics to detect diseases with significant unmet medical needs, today announced […]

Heart & Vascular Center at Valley View Offers Open Heart Surgery and New Cardiothoracic Procedures, Under the Leadership of Cardiothoracic Surgeon Stephen Jones, MD

New Procedures Include Open Heart Surgery, Minimally Invasive Surgical Approaches for Atrial Fibrillation and Heart Valves, and Lung Cancer Operations GLENWOOD SPRINGS, Colo., June 9, 2021 /PRNewswire/ — The Heart & Vascular Center at Valley View is pleased to introduce new services to continue to provide patients with world-class, convenient and compassionate care on […]

InCarda Therapeutics Provides Corporate Update Highlighting New Phase 2 Data for InRhythm™ Program, Plans for Pivotal Phase 3 Study and Expansion of Senior Management Team

Positive Data from Completed InRhythm Phase 2 Study Demonstrate Safe and Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Plans to Initiate RESTORE1: Single Pivotal Phase 3 Trial in Atrial Fibrillation in Q3 2021; Data Expected 2H 2022 Appointment of Angela Wang as CFO Strengthens Management Team and Supports […]